查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1629319

吸入胶囊市场，按配方、应用、释放机制、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Inhalation Capsules Market, By Formulation, By Application, By Release Mechanism, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年吸入胶囊市场规模为8.319亿美元，2024年至2032年复合年增长率为6.50%。

吸入胶囊市场-市场动态

呼吸道疾病盛行率上升推动市场需求

呼吸系统疾病盛行率的上升是推动医药市场对吸入胶囊需求的重要因素。由于空气污染、吸烟、人口老化和遗传倾向等因素，气喘、慢性阻塞性肺病 (COPD) 和其他肺部相关疾病等呼吸系统疾病变得更加常见。这些病症通常需要长期管理，吸入疗法被认为是最有效的治疗选择之一，可以提供快速且有针对性的缓解。

随着呼吸系统疾病数量的增加，对更有效、更方便的治疗方法的需求也随之增加。吸入胶囊可提供精确的剂量并有效地将药物直接输送至肺部，正在成为哮喘和慢性阻塞性肺病等患者的首选。这些胶囊可以更好地在肺部吸收药物，改善治疗效果并减少口服治疗中出现的全身性副作用的频率。突显这一趋势的一项统计数据是，据世界卫生组织(WHO) 称，预计到2030 年，慢性阻塞性肺病将成为全球第三大死亡原因。病率的不断上升，刺激了对慢性阻塞性肺病的需求。因此，随着製药公司不断开发创新解决方案来解决这些广泛存在的呼吸系统疾病，吸入胶囊市场预计将显着增长。

吸入胶囊市场 - 关键见解

  • 根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 6.50% 左右的复合年增长率成长
  • 根据配方细分，预计粉吸入胶囊将在 2023 年占据最大市场份额
  • 根据应用细分，气喘是 2023 年的领先细分市场
  • 按地区划分，北美是 2023 年的主要收入来源

吸入胶囊市场-細項分析：

全球吸入胶囊市场根据配方、应用、释放机制和地区进行细分。

市场依剂型分为三类：粉末吸入胶囊和液体填充胶囊。粉末吸入胶囊领域在市场上占据主导地位。由于几个关键因素，粉末吸入胶囊行业在市场上占据主导地位。首先，它们将有效的药物直接输送到肺部，这是气喘和慢性阻塞性肺病等疾病最需要的地方。细粉末确保深入肺部渗透，最大限度地发挥药物的功效。

根据应用，市场分为两类：气喘、慢性阻塞性肺病、肺部感染和肺动脉高压。气喘在市场上占据主导地位，并且由于其高盛行率、环境触发因素和持续的治疗进展，在预测期内可能会保持其主导地位。全球有超过 2.6 亿人患有气喘，使其成为最常见的慢性呼吸道疾病之一。庞大的患者群体推动了对气喘治疗（包括吸入疗法）的持续需求

吸入胶囊市场 - 地理洞察

由于呼吸系统疾病的盛行率不断上升以及先进给药系统的日益采用，吸入胶囊市场在各个地区都在成长。由于完善的医疗基础设施、高额医疗支出以及大量患有气喘和慢性阻塞性肺病等呼吸系统疾病的患者群体，北美占据了相当大的份额。欧洲也发挥关键作用，人口老化不断加剧，强大的医疗保健系统支持吸入疗法的采用。在亚太地区，由于呼吸道疾病发病率上升、医疗基础设施不断扩大以及政府旨在改善医疗保健可近性的倡议，预计市场将快速成长。由于吸烟率上升、城市化和空气污染，拉丁美洲的需求不断增加，而中东和非洲面临日益严重的呼吸道疾病负担，但获得先进医疗保健的机会却更加有限。然而，这些地区持续的医疗保健改善预计将推动未来市场的成长。

吸入胶囊市场-竞争格局：

由于对有效呼吸治疗的需求不断增长以及药物输送技术的不断进步，吸入胶囊市场竞争激烈。公司正在专注于开发创新的吸入产品，特别是干粉吸入器（DPI），其改进的配方可提供更好的生物利用度和更快的起效。製药公司、研究机构和医疗保健提供者之间的策略伙伴关係和合作对于扩大市场覆盖范围和增强产品供应至关重要。此外，确保监管合规性并获得不同地区卫生当局的批准对于市场参与者保持竞争力和维持产品可用性至关重要，从而进一步推动市场的成长。

最新进展：

  • 2024 年 2 月，康泰伦特宣布在其马萨诸塞州波士顿工厂增加了吸入干粉的强效胶囊填充能力。此次扩张旨在满足製药业对复杂药物输送解决方案不断增长的需求。新功能将支援客户开发吸入疗法，增强康泰伦特在生物製剂和先进药物製剂领域的产品。
  • 2023 年8 月，Lupin 在美国推出了用于治疗慢性阻塞性肺病的噻托铵干粉吸入器，透过具有成本效益的解决方案扩大了其呼吸产品组合，旨在改善患者获得这一关键治疗的机会。
  • 2024 年 6 月，Verona Pharma 宣布美国 FDA 批准 Ohtuvayre(TM)（ensifentrine），一种治疗慢性阻塞性肺病（COPD）的新型疗法，标誌着该公司呼吸治疗产品线的一个重要里程碑。该批准预计将透过在单一吸入疗法中结合支气管扩张剂和抗发炎特性来加强对慢性阻塞性肺病症状的管理，为目前治疗无法充分控制的患者提供新的选择。

目录

第 1 章：吸入胶囊市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按配方分類的吸入胶囊市场片段
    • 吸入胶囊市场片段（依应用）
    • 吸入胶囊市场片段（依释放机制）
    • 按国家/地区分類的吸入胶囊市场片段
    • 按地区分類的吸入胶囊市场片段
  • 竞争洞察

第 3 章：吸入胶囊主要市场趋势

  • 吸入胶囊市场驱动因素
    • 市场驱动因素的影响分析
  • 吸入胶囊市场限制
    • 市场限制影响分析
  • 吸入胶囊市场机会
  • 吸入胶囊市场未来趋势

第 4 章：吸入胶囊产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：吸入胶囊市场：地缘政治紧张局势升级的影响

  • COVID-19 大流行的影响
  • 俄罗斯-乌克兰战争的影响
  • 中东衝突的影响

第 6 章：吸入胶囊市场格局

  • 2023 年吸入胶囊市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：吸入胶囊市场 - 按配方

  • 概述
    • 按配方分類的细分市场占有率分析
    • 粉状吸入胶囊
    • 液体填充胶囊

第 8 章：吸入胶囊市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 气喘
    • 慢性阻塞性肺臟疾病
    • 肺部感染
    • 肺循环血压过高

第 9 章：吸入胶囊市场 - 按释放机制

  • 概述
    • 按发行机制分類的细分市占率分析
    • 立即发布
    • 受控释放

第 10 章：吸入胶囊市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美吸入胶囊主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按配方）
    • 北美市场规模和预测（按应用）
    • 北美市场规模与预测（按发布机制）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲吸入胶囊主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按配方）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模与预测（按发布机制）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区吸入胶囊主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 按配方分類的亚太市场规模和预测
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模与预测（按发布机制）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲吸入胶囊主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按形式）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模与预测（按发布机制）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲吸入胶囊主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按配方）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模及预测（按发布机制）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 吸入胶囊产业

  • 竞争仪表板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • AstraZeneca PLC
    • GlaxoSmithKline plc
    • Novartis International AG
    • Cipla Limited
    • Boehringer Ingelheim GmbH
    • Merck & Co., Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Lupin Pharmaceuticals, Inc.
    • UCB SA
    • Hovione
    • Dr. Reddy's Laboratories Ltd.
    • Laboratorios Farmaceuticos Rovi, SA
    • Vectura Group plc
    • MannKind Corporation
    • Catalent Pharma Solutions
    • Pfizer Inc.
    • Ferring Pharmaceuticals Inc.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4501

REPORT HIGHLIGHT

Inhalation Capsules Market size was valued at USD 831.90 Million in 2023, expanding at a CAGR of 6.50% from 2024 to 2032.

Inhalation capsules are specialized pharmaceutical capsules containing powdered medication intended for delivery directly into the lungs through inhalation. These capsules are used with inhalation devices and are designed to ensure the medication reaches the lungs efficiently. This method of drug delivery is particularly important for respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD), where localized treatment is crucial. The inhalation route allows for faster onset of action compared to oral medications, as it bypasses the digestive system, providing quicker relief. Additionally, it reduces the risk of systemic side effects since the drug is targeted directly to the lungs, improving the overall effectiveness and safety of treatment.

Inhalation Capsules Market- Market Dynamics

Rising prevalence of respiratory diseases to propel market demand

The rising prevalence of respiratory diseases is a significant factor driving the demand for inhalation capsules in the pharmaceutical market. Respiratory diseases, such as asthma, chronic obstructive pulmonary disease (COPD), and other lung-related conditions, have become more common due to factors like air pollution, smoking, aging populations, and genetic predispositions. These conditions often require long-term management, and inhalation therapies are considered one of the most effective treatment options, offering rapid and targeted relief.

As respiratory diseases grow in number, the need for more effective and convenient treatments also rises. Inhalation capsules, which provide a precise dosage and efficient drug delivery directly to the lungs, are becoming a preferred choice for patients with conditions like asthma and COPD. These capsules allow for better drug absorption in the lungs, improving therapeutic outcomes and reducing the frequency of systemic side effects seen with oral treatments. One statistic that highlights this trend is that, according to the World Health Organization (WHO), COPD is expected to become the third leading cause of death worldwide by 2030. This increase in COPD cases, alongside the growing asthma prevalence, fuels the demand for effective inhalation therapies. As a result, the inhalation capsule market is projected to experience significant growth as pharmaceutical companies continue to develop innovative solutions to address these widespread respiratory conditions.

Inhalation Capsules Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.50% over the forecast period (2024-2032)
  • Based on formulation segmentation, Powdered Inhalation Capsules was predicted to show maximum market share in the year 2023
  • Based on application segmentation, Asthma was the leading segment in 2023
  • On the basis of region, North America was the leading revenue generator in 2023

Inhalation Capsules Market- Segmentation Analysis:

The Global Inhalation Capsules Market is segmented on the basis of Formulation, Application, Release Mechanism and Region.

The market is divided into three categories based on formulation: powdered inhalation capsules, and liquid-filled capsules. The powdered inhalation capsules sector dominates the market. The powdered inhalation capsules sector dominates the market due to several key factors. First, they provide efficient drug delivery directly to the lungs, where they are most needed for conditions like asthma and COPD. The fine powder ensures deep lung penetration, maximizing the drug's effectiveness.

The market is divided into two categories based on application: asthma, chronic obstructive pulmonary disease, pulmonary infections, and pulmonary hypertension. Asthma dominates the market and is likely to maintain its dominance during the forecast period due to its high prevalence, environmental triggers, and ongoing treatment advancements. Over 260 million people worldwide suffer from asthma, making it one of the most common chronic respiratory diseases. This large patient population drives continuous demand for asthma treatments, including inhalation therapies

Inhalation Capsules Market- Geographical Insights

The inhalation capsules market is experiencing growth across various regions due to the increasing prevalence of respiratory diseases and the rising adoption of advanced drug delivery systems. North America holds a significant share, driven by a well-established healthcare infrastructure, high healthcare spending, and a large patient population with respiratory conditions like asthma and COPD. Europe also plays a key role, with a growing aging population and strong healthcare systems supporting the adoption of inhalation therapies. In Asia-Pacific, rapid market growth is expected, fueled by rising respiratory disease incidences, expanding healthcare infrastructure, and government initiatives aimed at improving healthcare access. Latin America is seeing increased demand due to rising smoking rates, urbanization, and air pollution, while the Middle East and Africa face a growing respiratory disease burden but have more limited access to advanced healthcare. However, ongoing healthcare improvements in these regions are expected to drive future market growth.

Inhalation Capsules Market- Competitive Landscape:

The inhalation capsules market is highly competitive, driven by the increasing demand for effective respiratory treatments and continuous advancements in drug delivery technologies. Companies are focusing on developing innovative inhalation products, particularly dry powder inhalers (DPIs), with improved formulations that offer better bioavailability and faster onset of action. Strategic partnerships and collaborations between pharmaceutical companies, research organizations, and healthcare providers are crucial in expanding market reach and enhancing product offerings. Additionally, ensuring regulatory compliance and obtaining approvals from health authorities across different regions is vital for market players to stay competitive and maintain product availability, further fueling the growth of the market.

Recent Developments:

  • In February 2024, Catalent announced the addition of potent capsule filling capabilities for inhaled dry powders at its Boston, MA facility. This expansion aims to meet the growing demand for complex drug delivery solutions in the pharmaceutical industry. The new capabilities will support clients developing inhalation therapies, enhancing Catalent's offerings in the field of biologics and advanced drug formulations.
  • In August 2023, Lupin launched its Tiotropium Dry Powder Inhaler in the United States for the treatment of COPD, expanding its respiratory portfolio with a cost-effective solution aimed at improving patient access to this critical therapy.
  • In June 2024, Verona Pharma announced the U.S. FDA approval of Ohtuvayre(TM) (ensifentrine), a novel treatment for chronic obstructive pulmonary disease (COPD), marking a significant milestone in the company's respiratory therapeutics pipeline. The approval is expected to enhance the management of COPD symptoms by combining both bronchodilator and anti-inflammatory properties in a single inhaled therapy, offering a new option for patients who are not adequately controlled with current treatments.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INHALATION CAPSULES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Novartis International AG
  • Cipla Limited
  • Boehringer Ingelheim GmbH
  • Merck & Co., Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Lupin Pharmaceuticals, Inc.
  • UCB S.A.
  • Hovione
  • Dr. Reddy's Laboratories Ltd.
  • Laboratorios Farmaceuticos Rovi, S.A.
  • Vectura Group plc
  • MannKind Corporation
  • Catalent Pharma Solutions
  • Pfizer Inc.
  • Ferring Pharmaceuticals Inc.
  • Others

GLOBAL INHALATION CAPSULES MARKET, BY FORMULATION TYPE- MARKET ANALYSIS, 2019 - 2032

  • Powdered Inhalation Capsules
  • Liquid-filled Capsules

GLOBAL INHALATION CAPSULES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Infections
  • Pulmonary Hypertension

GLOBAL INHALATION CAPSULES MARKET, BY RELEASE MECHANISM- MARKET ANALYSIS, 2019 - 2032

  • Immediate Release
  • Controlled Release

GLOBAL INHALATION CAPSULES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Inhalation Capsules Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Inhalation Capsules Market Snippet by Formulation
    • 2.1.2. Inhalation Capsules Market Snippet by Application
    • 2.1.3. Inhalation Capsules Market Snippet by Release Mechanism
    • 2.1.4. Inhalation Capsules Market Snippet by Country
    • 2.1.5. Inhalation Capsules Market Snippet by Region
  • 2.2. Competitive Insights

3. Inhalation Capsules Key Market Trends

  • 3.1. Inhalation Capsules Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Inhalation Capsules Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Inhalation Capsules Market Opportunities
  • 3.4. Inhalation Capsules Market Future Trends

4. Inhalation Capsules Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Inhalation Capsules Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Inhalation Capsules Market Landscape

  • 6.1. Inhalation Capsules Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Inhalation Capsules Market - By Formulation

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Formulation, 2023 & 2032 (%)
    • 7.1.2. Powdered Inhalation Capsules
    • 7.1.3. Liquid-filled Capsules

8. Inhalation Capsules Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Asthma
    • 8.1.3. Chronic Obstructive Pulmonary Disease
    • 8.1.4. Pulmonary Infections
    • 8.1.5. Pulmonary Hypertension

9. Inhalation Capsules Market - By Release Mechanism

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Release Mechanism, 2023 & 2032 (%)
    • 9.1.2. Immediate Release
    • 9.1.3. Controlled Release

10. Inhalation Capsules Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Inhalation Capsules Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Inhalation Capsules Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Inhalation Capsules Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Inhalation Capsules Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Inhalation Capsules Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Inhalation Capsules Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. AstraZeneca PLC
    • 11.2.2. GlaxoSmithKline plc
    • 11.2.3. Novartis International AG
    • 11.2.4. Cipla Limited
    • 11.2.5. Boehringer Ingelheim GmbH
    • 11.2.6. Merck & Co., Inc.
    • 11.2.7. Sun Pharmaceutical Industries Ltd.
    • 11.2.8. Teva Pharmaceutical Industries Ltd.
    • 11.2.9. Lupin Pharmaceuticals, Inc.
    • 11.2.10. UCB S.A.
    • 11.2.11. Hovione
    • 11.2.12. Dr. Reddy's Laboratories Ltd.
    • 11.2.13. Laboratorios Farmaceuticos Rovi, S.A.
    • 11.2.14. Vectura Group plc
    • 11.2.15. MannKind Corporation
    • 11.2.16. Catalent Pharma Solutions
    • 11.2.17. Pfizer Inc.
    • 11.2.18. Ferring Pharmaceuticals Inc.
    • 11.2.19. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us